OTC : DMPHF

Dermapharm Holding SE — Earnings Estimates

$47.69 USD

-$5.31 (-10.02%)

Volume
100
Average Volume
1
Market Capitalization
$2.36B
P/E Ratio
15.46
Dividend Yield
2.12%
Price Target
Year High
$53.00
Year Low
$39.56
Day High
—
Day Low
—
Payout Ratio
$0.34
Current Ratio
$2.00

Annual earnings financials

DMPHF financial data with annual/quarterly toggle

DMPHF GAAP EPS - Annual & Quarterly

DMPHF Sales Revenue - Annual & Quarterly

DMPHF Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

DMPHF Estimated and Actual Revenue by Quarter
DMPHF Estimated and Actual EPS by Quarter
DMPHF Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 1 89.35M 89.35M 89.35M 65.2M 65.2M 65.2M
2026-09-30 1 89.35M 89.35M 89.35M 65.2M 65.2M 65.2M
2026-06-30 1 81.93M 81.93M 81.93M 59.79M 59.79M 59.79M
2026-03-31 1 89.88M 89.88M 89.88M 65.59M 65.59M 65.59M
2025-12-31 1 86.53M 86.53M 86.53M 63.15M 63.15M 63.15M
2025-09-30 1 88.57M 88.57M 88.57M 64.64M 64.64M 64.64M
DMPHF Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 1 - - - 22.37M 22.37M 22.37M
2026-09-30 1 - - - 22.37M 22.37M 22.37M
2026-06-30 1 - - - 20.51M 20.51M 20.51M
2026-03-31 1 45.4M 45.4M 45.4M 22.5M 22.5M 22.5M
2025-12-31 1 22.07M 22.07M 22.07M 21.66M 21.66M 21.66M
2025-09-30 1 - - - 22.17M 22.17M 22.17M
DMPHF Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 1 305.1M 305.1M 305.1M 0 0 0 0
2026-09-30 1 305.1M 305.1M 305.1M 0 0 0 0
2026-06-30 1 279.78M 279.78M 279.78M 0 0 0 0
2026-03-31 1 306.93M 306.93M 306.93M 1 0.84319 0.84319 0.84319
2025-12-31 1 295.49M 295.49M 295.49M 1 0.40985 0.40985 0.40985
2025-09-30 1 302.46M 302.46M 302.46M 0 0 0 0